Use of GLP-1 receptor agonists for type 2 diabetes treatment intensification after basal insulin failure. [electronic resource]
- Diabetes & metabolism Apr 2017
- 2S34-2S38 p. digital
Publication Type: Journal Article; Review
1878-1780
10.1016/S1262-3636(17)30071-X doi
Diabetes Mellitus, Type 2--drug therapy Humans Hypoglycemic Agents--therapeutic use Insulin--therapeutic use Retreatment Treatment Failure Glucagon-Like Peptide-1 Receptor Agonists